New virtual care pathway for older adults with chronic diseases
Official title: Feasibility and Economic Evaluation of a Teleconsultation Care Pathway for Older Patients With Noncommunicable Diseases at an Academic Primary Care Clinic in Kuala Lumpur, Malaysia
Run by National University of Malaysia · NCT07843238 · Data updated 2026-11-12
A teleconsultation-based care pathway for adults 60+ with hypertension, diabetes, or dyslipidemia to see if it’s feasible and cost-saving in Malaysian primary care compared with usual clinic visits.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 60 Years and up |
| Sex | All |
| Enrollment | 160 (estimated) |
| Sponsor | National University of Malaysia Academic / other |
| Locations | 1 site (Kuala Lumpur) |
| Status | Recruiting |
| Started | September 2, 2026 |
| Main results expected | August 31, 2027 |
| Study ends | August 31, 2027 |
| Registry record updated | October 16, 2026 |
| Trial ID | NCT07843238 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults aged 60 and older with hypertension, diabetes, or dyslipidemia who are literate in Malay or English, not frail, have internet access, and can use a smartphone or get help from a caregiver.
✕Probably not a fit
Patients who require in-person procedures, are newly referred, or have no internet access may not benefit from this telehealth approach.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This interventional study tests a telehealth program called TeleCOOP-NCD© for older adults with chronic conditions in Malaysia. Participants will use teleconsultations to manage hypertension, diabetes, and dyslipidemia, and researchers will compare costs, patient satisfaction, quality of life, and clinical parameters to standard in-clinic care. The study will evaluate feasibility, recruitment and retention, and economic impact, including costs borne by patients and providers. Primary outcomes include blood pressure, HbA1c, and fasting glucose, along with patient-reported outcomes. The trial will be conducted in Kuala Lumpur at Klinik Primer - Hospital Canselor Tuanku Muhriz under the National University of Malaysia.
Why it matters
Potential benefit: If successful, patients could experience lower overall costs and convenient access to care without compromising disease control.
How similar studies have gone: Telehealth approaches for chronic disease management have shown mixed but promising results in improving access and satisfaction, with ongoing evaluation of cost-effectiveness.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patients with the age of 60 years and above; * Patients who are literate in either Malay or English language; * Patients who are not frail or mildly frail (with the scores of 0-8 in the Pictorial Fit-Frail Scale assessment); * Patients who are receiving treatment for hypertension, diabetes and/or dyslipidemia (any of the three NCDs); and * Patients who have internet access and know how to operate a smartphone/device or are able to receive assistance for its use from their family members or caregivers. Exclusion Criteria: * Patients who are completely transferred out from the Klinik Primer or Hospital Canselor Tuanku Muhriz (HCTM); * Patients who are newly referred to the clinic and attending their first visit; * Patients who visit the clinic for teaching sessions or non-doctor consultations (allied health, procedures, or prescription refill).
Where it's running
-
Klinik Primer - Hospital Canselor Tuanku Muhriz (KP-HCTM)
Kuala Lumpur, Malaysia Recruiting
Study contacts
- Principal investigator: Aznida Firzah Abdul Aziz, MBBS, MMed, PhD — Department of Family Medicine, Faculty of Medicine, Universiti Kebangsaan Malaysia
- Study coordinator: Principal Investigator
- Email: draznida@gmail.com
- Phone: +60391455555
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Guiding Optimal Blood Pressure in Peritoneal Dialysis
This pilot tests whether aiming for a lower systolic blood pressure target (<120 mmHg) is feasible and practical for adults with end-stage kidney disease on peritoneal dialysis, compared to a <140 mmHg target.
-
High BMI and periodontitis in Thai adults under 60
This study tests how common high BMI and periodontitis are among Thai adults aged 18–59 and what factors are linked to them.
-
Benefits of Retained Insulin for Good Health in Diabetes
This study tests whether preserving or restoring a person’s own insulin production can improve quality of life and blood sugar control for people who need insulin to manage diabetes.
-
Improving Care for underserved older Black patients with cardiovascular and other chronic conditions
This study tests a culturally tailored approach to patient-centered care for older African American patients with cardiovascular disease and other conditions who receive care at a community hospital.
-
ECC4703 with Sulfasalazine and Pitavastatin in adults with NAFLD and dyslipidemia
This early study tests whether adding ECC4703 to sulfasalazine and pitavastatin is safe and how the body handles the combination in adults with fatty liver disease and high cholesterol.
-
Myokines in metabolic and endocrine diseases linked to sarcopenia
This study tests whether myokines can serve as biomarkers or drivers of sarcopenia and sarcopenic obesity in people with metabolic or endocrine diseases.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.